Nevertheless, the underlying mechanism of how PIK3R1 mediates resistance to chemotherapy and whether this involves canonical PI3K signaling and downstream BRCA1 activity remains to be investigated in GC. The gene discussed is BRCA1; the disease is gastric cancer.